Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04434092 |
|---|---|
| Brief Title: | A Phase III Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibitors. (COMMODORE 2) |
| First Submitted : | June 3, 2020 |
| First Submitted that Met QC Criteria : | June 12, 2020 |
| First Posted : | June 16, 2020 |
| Certification/Extension First Submitted : | November 15, 2023 |
| Certification/Extension First Posted : | November 18, 2023 |
| Last Update Submitted that Met QC Criteria : | May 15, 2024 |
| Last Update Posted : | May 16, 2024 (Estimate) |